Skip to main content

Table 2 Assessment table of participants in LINC-II study (n = 240)

From: Design of a randomized controlled trial to Link Infectious and Narcology Care (LINC-II) in St. Petersburg, Russia

Administered assessment

Study time point

Baseline

6-month

12-month

Demographics [24,25,26]

X

 

X

HIV testing and HCV diagnosis [27]

X

 

X

ART use and adherence [28]

X

X

X

Health care utilization [29]

X

X

X

Costs of illness and treatment in last month

X

X

X

Attitudes toward care coordination and care continuity [30]

X

X

X

Barriers to medical care [31]

X

X

X

Perceived discrimination in health care

X

X

X

DSM-5 opioid use disorder

X

  

Drug use [32, 33]

X

X

X

TLFB: opioids [34, 35]

X

X

X

Tobacco use [36, 37]

X

  

Alcohol use: AUDIT [38]

X

 

X

Opportunistic infections [39]

 

X

X

Medications

X

X

X

Pain assessment [40, 41]

 

X

X

HIV sex risk behaviors and reproductive health [42, 43]

  

X

Sexual partnersa

X

 

X

HIV risk categoriesa [44, 45]

X

  

HIV disclosurea [46, 47]

X

  

HIV stigmaa [48]

X

 

X

Substance use stigmaa

X

 

X

Barriers to medical care part 2a [31]

X

X

X

Depressive symptoms (CES-D)a [49, 50]

X

 

X

Anxiety (GAD-7)a [51]

X

 

X

Case manager questionsa

 

X

X

Partner violence and sexual assaulta [52]

 

X

 

Overdose and suicidea

 

X

X

Social support scale [53]

X

  

VR-12 health survey—MOS-HIV [54, 55]

X

 

X

Primary activity

X

X

X

Visit costs

 

X

X

  1. aSelf-administered